No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AGEN Agenus
- 12.990
- -1.310-9.16%
Close Jun 18 16:00 ET
- 13.230
- +0.240+1.85%
Post 19:07 ET
272.78MMarket Cap-1036P/E (TTM)
14.090High12.340Low1.37MVolume13.940Open14.300Pre Close17.76MTurnover7.75%Turnover RatioLossP/E (Static)21.00MShares38.60052wk High-1.35P/B229.22MFloat Cap4.77552wk Low--Dividend TTM17.65MShs Float8419.554Historical High--Div YieldTTM12.24%Amplitude4.775Historical Low12.984Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Agenus: Buell's Appointment Effective Immediately >AGEN
Agenus: Buell's Appointment Effective Immediately >AGEN
Agenus Appoints Jennifer Buell Chairman of Executive Council >AGEN
Agenus Appoints Jennifer Buell Chairman of Executive Council >AGEN
Express News | Agenus Announces Appointment of DR. Jennifer Buell to Its Board of Directors
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersENDRA Life Sciences (NASDAQ:NDRA) stock increased by 71.6% to $0.15 during Wednesday's pre-market session. The company's market cap stands at $1.5 million. Concord Medical Services (NYSE:CCM) s
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Core & Main Inc (NYSE:CNM) fell sharply during Tuesday's session after the company reported mixed first-quarter financial results.Core & Main posted quarterly earnings of 49 cents per share,
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 20 points on Tuesday.Shares of Saia Inc (NASDAQ:SAIA) rose sharply during today's pre-market trading session after the company reported
Comments
So $Agenus(AGEN.US$ owner bought shares at some low price at 0.6, then the price went down to 0.3 then reverse split.
Now the price is $15.00. Sometimes things get worse before it get better.
You could be a day trader and make your profit or cut losses or an investor and hold on.
I see some possibilities in this company and reverse split is to consolidate compliance. Now the ethics of the management or if they consider investor or shareholder investment is another d...
Now the price is $15.00. Sometimes things get worse before it get better.
You could be a day trader and make your profit or cut losses or an investor and hold on.
I see some possibilities in this company and reverse split is to consolidate compliance. Now the ethics of the management or if they consider investor or shareholder investment is another d...
2
$Agenus(AGEN.US$ Reuters· 5 mins ago
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/Bal Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/Bal Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
$Agenus(AGEN.US$ I knew the momentum wouldn't last.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg